|Title:||Protocol for Administering tPA in Acute Ischaemic Stroke|
|Document ID:||Operational Directive OD 0319/11|
|Date of issue:||Friday, 8 April 2011|
|Status:||NO LONGER APPLICABLE|
|Description:||The administration of Altepase must be given up to 4.5 hours after stroke onset to dissolve thrombus, restoring flow of blood to the brain. The clinical guideline outlines the eligibility criteria and protocols for administration of Altepase.|
|Applicable to:||Health Professionals within the authority to administer Altepase.|
|Period of effect:||from 1 February 2011 to 1 February 2016|
|Review date:||1 February 2016|
|Authorised by:||Kim Snowball, Director General, Department of Health WA, 05-Feb-2011|
|Print version:||View print version|
Protocol for Administering tPA in Acute Ischaemic Stroke
In April 2010, approval was given to distribute the Protocol for Administering tPA in Acute Ischaemic Stroke as an operational directive. The Protocol has been revised as a result of input from the Pharmacy Group around prescribing as alteplase rather than tPA.
Changes also reflect:
This clinical guideline was developed through the Neurosciences Advisory Group and has been endorsed by the Neurosciences and the Senses Health Network Executive Advisory Group and approved by the Chief Medical Officer.
This circular last updated: Friday, 8 April 2011 at 2:22pm